R. Scott Struthers
Founder, Chief Executive Officer and Director
Biosciences
Crinetics Pharmaceuticals Inc
United States of America
Biography
Dr. R. Scott Struthers, Ph.D. founded Crinetics Pharmaceuticals, Inc. in 2008 and serves as its Chief Executive Officer. Prior to Crinetics, Dr. Struthers served as Senior Director and Head, Endocrinology and Metabolism at Neurocrine Biosciences. At Neurocrine, he initiated and led its efforts to discover and develop orally active, nonpeptide GnRH antagonists. This resulted in a first-in-class compound, elagolix, which has demonstrated safety and efficacy in over 40
Research Interest
Biosciences
